Guselkumab in East Asians With Moderate‐to‐Severe Ulcerative Colitis: Subgroup Analysis of the QUASAR Induction and Maintenance Studies

Documenti analoghi

• High Incidence of Metachronous Lesions After Endoscopic Removal in Patients With Ulcerative Colitis: Results of a Long‐Term Follow‐Up in Multicenter Registry Study
  di: Shunichi Yanai, et al.
  Pubblicazione: (2026)
• Editorial: To Stop or Not to Stop, Is It Still a Question? Authors' Reply
  di: Jeongkuk Seo, et al.
  Pubblicazione: (2024)
• Editorial: Another brick in the CDST wall: Authors' reply
  di: Kyuwon Kim, et al.
  Pubblicazione: (2024)
• Clinical Significance of Endoscopic Improvement at 6 Months in Patients With Ulcerative Colitis Treated With Ustekinumab: A Retrospective Real‐world Analysis
  di: Hiromu Morikubo, et al.
  Pubblicazione: (2026)
• Prospective Questionnaire Survey on Adherence to Oral 5‐Aminosalicylic Acid in Patients With Ulcerative Colitis
  di: Tsuyoshi Beppu, et al.
  Pubblicazione: (2025)